LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED

Substance profile for UNII 2165RE0K14, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII: 2165RE0K14
Preferred term: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED
Registry number: 9004-64-2
Ingredient type: UNSPECIFIED INGREDIENT

Chemical And Database Identifiers#

RxCUI: 1363584
PubChem: 0
NCIt: C80901
INN ID: 0

Open Chemistry Sources#

Source, Identifier, Link table
Source	Identifier	Link
RxNorm	1363584	https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1363584
NCI Thesaurus	C80901	https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80901
FDA Substance Registration System	2165RE0K14	https://precision.fda.gov/uniisearch/srs/unii/2165RE0K14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	VALSARTAN AND HYDROCHLOROTHIAZIDE	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GABAPENTIN	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	085a57b6-75f5-4ecc-b831-11383f5f68a7	3
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	c4104df9-2f42-45ed-bf26-112ec418cd6b	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	a82d6af7-0fbe-4b82-af3f-c017227b668c	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Promethazine Hydrochloride Tablets USP	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use atovaquone and proguanil hydrochloride tablets safely and effectively. See full prescribing information for atovaquone and proguanil hydrochloride tablets . ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS, for oral administration Initial U.S. Approval: 2000	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 1983	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 1997	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 2000	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 1997	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Mirtazapine Tablets, USP 7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 1995	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Famotidine Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 1997	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Mirtazapine Tablets, USP 7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Mirtazapine Tablets, USP 7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. Clopidogrel Tablets, USP Initial U.S. Approval: 1997	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets, USP Initial U.S. Approval: 1997	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Gabapentin Tablets, USP 600 mg and 800 mg Allied Pharma Inc	5
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Atovaquone and Proguanil Hydrochloride Tablets	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Atovaquone and Proguanil Hydrochloride Tablets	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Atovaquone and Proguanil Hydrochloride Tablets	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Cefprozil Tablets USP, 250 mg and 500 mg	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Famotidine Tablets USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Famotidine Tablets, USP 20 mg	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine tablets. Olanzapine Tablets, for Oral use Initial U.S. Approval: 1996	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Famotidine Tablets, USP	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Famotidine Tablets, USP	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Promethazine Hydrochloride Tablets USP	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets, for Oral use Initial U.S. Approval: 1996	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium and Hydrochlorothiazide Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Atovaquone and Proguanil Hydrochloride Tablets	1
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 2000	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Promethazine Hydrochloride Tablets USP	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium and Hydrochlorothiazide Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Promethazine Hydrochloride Tablets USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Losartan Potassium Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 2000	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	cd879bd1-38c0-4f72-904b-cf07f3186342	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Mirtazapine Tablets, USP	1
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules For oral administration Initial U.S. Approval: 1995	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Divalproex Sodium Delayed-Release Tablets USP 125 mg, 250 mg and 500 mg	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Gabapentin Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PREVPAC ® (lansoprazole 30 mg capsules, amoxicillin 500 mg capsules, USP, and clarithromycin 500 mg tablets, USP)	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	1c47fd79-c0ca-42d6-9910-774272b25bc1	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	c83616c9-c222-4e3e-91bd-c7839406bb2a	1
Hydroxypropyl Cellulose, Low Substituted	INACTIVE INGREDIENT	2165RE0K14	b3136363-6fcb-486d-b752-d53a1f8e2d69	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995	2
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	Gabapentin Tablets, USP	1
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	DIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	3983
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	3956
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MIRTAZAPINE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	3919
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	BENICAR HCT (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	3580
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1005
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]	1001
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PROMETHAZINE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]	1001
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	ATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1000
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK]	1000
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1000
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]	1000
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	28
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	EFFIENT (PRASUGREL HYDROCHLORIDE) TABLET, FILM COATED [ELI LILLY AND COMPANY ]	25
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MIRTAZAPINE (MIRTAZAPINE) TABLET [REMEDYREPACK INC. ]	25
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LAMICTAL (LAMOTRIGINE) TABLET LAMICTAL (LAMOTRIGINE) TABLET, CHEWABLE LAMICTAL ODT (LAMOTRIGINE) TABLET, ORALLY DISINTEGRATING LAMICTAL (LAMOTRIGINE) KIT [GLAXOSMITHKLINE LLC]	24
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR.REDDY'S LABORATORIES LTD.]	18
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AUROBINDO PHARMA LIMITED]	16
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]	16
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GEMFIBROZIL TABLET [NORTHSTAR RXLLC]	15
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MEFLOQUINE HYDROCHLORIDE TABLET [SANDOZ INC]	15
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	OMEPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC]	14
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	CLOPIDOGREL TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]	13
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSARTAN POTASSIUM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	12
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	12
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [MYLAN PHARMACEUTICALS INC.]	11
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	LIVALO (PITAVASTATIN CALCIUM) TABLET, FILM COATED [ELI LILLY AND COMPANY]	11
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [ZYDUS PHARMACEUTICALS (USA) INC.]	11
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSORTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET, FILM COATED [ZYDUS PHARMACEUTICALS (USA) INC.]	11
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]	11
Hydroxypropyl Cellulose, Low Substituted	INACTIVE INGREDIENT	2165RE0K14	RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.]	11
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	SAMSCA (TOLVAPTAN) TABLET [OTSUKA AMERICA PHARMACEUTICAL INC.]	11
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	BENICAR HCT (OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [DAIICHI SANKYO, INC.]	10
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GABAPENTIN CAPSULE GABAPENTIN TABLET, FILM COATED [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]	10
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	RABEPRAZOLE SODIUM (RABEPRAZOLE) TABLET, DELAYED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]	10
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	FAMCICLOVIR TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	9
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	9
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	BENICAR (OLMESARTAN MEDOXOMIL) TABLET, FILM COATED [CARDINAL HEALTH]	8
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	DIVALPROEX SODIUM TABLET, DELAYED RELEASE [LUPIN PHARMACEUTICALS, INC.]	8
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSORTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET, FILM COATED [CARDINAL HEALTH]	8
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	OLANZAPINE TABLET OLANZAPINE TABLET, ORALLY DISINTEGRATING [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]	8
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	ZOLPIDEM (ZOLPIDEM TARTRATE) TABLET [WEST-WARD PHARMACEUTICAL CORP]	8
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLET, FILM COATED ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC.,USA]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	BENICAR (OLMESARTAN MEDOXOMIL) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	BENICAR HCT (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [CARDINAL HEALTH]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GABAPENTIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GABAPENTIN TABLET, FILM COATED [ZYDUS PHARMACEUTICALS (USA) INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LOSORTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	MIRTAZAPINE TABLET, FILM COATED [AUROLIFE PHARMA LLC]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	OLANZAPINE TABLET [ASCEND LABORATORIES, LLC]	7
Hydroxypropyl Cellulose, Low Substituted	INACTIVE INGREDIENT	2165RE0K14	OLANZAPINE TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	PREVACID 24 HR (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [NOVARTIS CONSUMER HEALTH, INC.]	7
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	PREVPAC (LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.]	7
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	ATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	6
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLENMARK GENERICS INC]	6
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	CLOPIDOGREL (CLOPIDOGREL BISULPHATE) TABLET, FILM COATED [ACCORD HEALTHCARE INC.]	6
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	6
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	GABAPENTIN TABLET, FILM COATED [UNIT DOSE SERVICES]	6
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SUN PHARMA GLOBAL FZE]	6

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	American Health Packaging	2026-06-11
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	REMEDYREPACK INC.	2026-06-04
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	REMEDYREPACK INC.	2026-06-02
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	PD-Rx Pharmaceuticals, Inc.	2026-05-28
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	BluePoint Laboratories \| Glenmark Pharmaceuticals Limited	2026-05-28
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Actelion Pharmaceuticals US, Inc. \| Butterworth Laboratories Ltd \| Wickham Micro Limited \| Almac Sciences Limited \| Almac Pharma Services Limited \| EUROFINS AMATSIGROUP SAS \| Eurofins Amatsi Analytics \| SGS Institut Fresenius GmbH \| Excella GmbH \| Konapharma AG \| Confarma France	2026-05-28
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Rite Aid Corporation	2026-05-27
Sacubitril and Valsartan	ANI Pharmaceuticals, Inc.	2026-05-27
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	A-S Medication Solutions	2026-05-27
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-22
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	BJWC	2026-05-21
Losartan Potassium	PD-Rx Pharmaceuticals, Inc.	2026-05-21
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	ANI Pharmaceuticals, Inc.	2026-05-20
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Rising Pharma Holdings, Inc. \| Aurobindo Pharma Limited	2026-05-19
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-15
Sertraline hydrochloride	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-14
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-14
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-13
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	ANI Pharmaceuticals, Inc.	2026-05-13
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-13
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-12
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-05-12
Losartan Potassium	Redpharm Drug	2026-05-12
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Cardinal Health 107, LLC	2026-05-11
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Cardinal Health 107, LLC	2026-05-07
Bupropion Hydrochloride XL	Coupler LLC \| LUPIN LIMITED	2026-05-06
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Coupler LLC	2026-05-06
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Otsuka America Pharmaceutical, Inc.	2026-05-06
Divalproex Sodium	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2026-05-05
metronidazole	ST. MARY'S MEDICAL PARK PHARMACY	2026-05-01
Bupropion Hydrochloride XL	REMEDYREPACK INC.	2026-05-01
Bupropion Hydrochloride	REMEDYREPACK INC.	2026-04-30
Gabapentin	PD-Rx Pharmaceuticals, Inc.	2026-04-29
Low-substituted hydroxypropyl cellulose, unspecified	Epizyme, Inc. \| Patheon Pharmaceuticals Inc. \| Sterling Pharma Solutions Limited	2026-04-29
Metronidazole	Coupler LLC	2026-04-29
Doxycycline Hyclate	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	2026-04-28
DAPAGLIFLOZIN	Florida Pharmaceutical Products, LLC \| Inventia Healthcare Limited. \| Inventia Healthcare Limited	2026-04-28
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Coupler LLC \| Aurobindo Pharma Limited	2026-04-27
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Umedica Laboratories USA Inc. \| UMEDICA LABORATORIES PRIVATE LIMITED	2026-04-26
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-04-24
Bupropion Hydrochloride	Quallent Pharmaceuticals Health LLC \| LUPIN LIMITED	2026-04-24
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Glenmark Pharmaceuticals Inc.,USA \| Glenmark Pharmaceuticals Limited	2026-04-24
Promethazine Hydrochloride	Sportpharm, Inc. dba Sportpharm	2026-04-24
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	REMEDYREPACK INC.	2026-04-23
Promethazine Hydrochloride	REMEDYREPACK INC.	2026-04-23
Lacosamide	Aurobindo Pharma Limited	2026-04-23
Olmesartan Medoxomil	REMEDYREPACK INC.	2026-04-22
Bupropion Hydrochloride XL	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2026-04-22
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	AMERISOURCEBERGEN DRUG CORPORATION	2026-04-17
Topiramate	Zydus Pharmaceuticals USA Inc. \| Zydus Worldwide DMCC \| Zydus Lifesciences Limited	2026-04-16
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	A-S Medication Solutions	2026-04-16
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	A-S Medication Solutions	2026-04-16
Metronidazole	St. Mary's Medical Park Pharmacy	2026-04-15
metyrosine	Amneal Pharmaceuticals NY LLC	2026-04-14
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-04-13
Gemfibrozil	Northstar RxLLC \| Piramal Pharma Limited	2026-04-10
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-04-10
PRASUGREL	Apotex Corp. \| PANACEA BIOTEC PHARMA LIMITED	2026-04-08
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Preferred Pharmaceuticals Inc.	2026-04-08
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Aurobindo Pharma Limited	2026-04-06
Sertraline hydrochloride	Granules Pharmaceuticals Inc. \| Granules India Limited	2026-04-06
CEFIXIME	REMEDYREPACK INC.	2026-04-06
RABEPRAZOLE SODIUM	REMEDYREPACK INC.	2026-04-06
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	A-S Medication Solutions	2026-04-02
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	A-S Medication Solutions	2026-04-02
metronidazole	REMEDYREPACK INC.	2026-04-01
Sacubitril and Valsartan	XLCare Pharmaceuticals Inc \| Evaric Pharmaceuticals Inc	2026-04-01
Topiramate	Zydus Pharmaceuticals USA Inc. \| Zydus Worldwide DMCC \| Zydus Lifesciences Limited	2026-03-30
Headache Relief Extra Strength	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	2026-03-25
Acid Reducer	Walgreens	2026-03-25
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Clinical Solutions Wholesale, LLC	2026-03-24
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	GlaxoSmithKline LLC	2026-03-23
low-substituted hydroxypropyl cellulose, unspecified	Nuvation Bio Inc.	2026-03-23
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	REMEDYREPACK INC.	2026-03-19
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Major Pharmaceuticals	2026-03-19
Gabapentin	PD-Rx Pharmaceuticals, Inc.	2026-03-18
Metronidazole	A-S Medication Solutions	2026-03-18
Sacubitril and Valsartan	Novugen Pharma (USA) LLC \| Novugen Pharma Sdn. Bhd. \| Aizant Drug Research Solutions Pvt. Ltd.	2026-03-17
LACOSAMIDE	Camber Pharmaceuticals, Inc. \| Annora Pharma Private Limited	2026-03-13
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED	Bryant Ranch Prepack	2026-03-13

LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED

Substance Identity#

Chemical And Database Identifiers#

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Related DailyMed Labels#